NewsRx

Search our medical news database

Research and Markets Ltd.

Generics Share to Rise in the Greek Pharmaceuticals Market Over the Next Five Years According to New Report

Published in Medical Patent Law Weekly, March 26th, 2008

Research and Markets has announced the addition of Greece Pharmaceuticals & Healthcare Report Q1 2008 to their offering.

The Greece Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Greece's pharmaceuticals and healthcare industry.

The Greek pharmaceutical market remains one of the least-developed of the European Union (EU)-15 markets. The generics segment accounts for only around 10% of the total market by value, although as the government realises the amount of potential savings made from higher usage of copy drugs, their share will rise over the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook